Related Experiment Videos
Insights
Silent myocardial ischemia requires careful definition. Asymptomatic individuals with abnormal stress tests typically have a benign prognosis, not warranting invasive procedures.
Area of Science:
- Cardiology
- Clinical Medicine
Context:
- The definition of "silent myocardial ischemia" has broadened, encompassing diverse patient groups.
- This includes asymptomatic individuals alongside those with symptomatic coronary artery disease or post-myocardial infarction.
Purpose:
- To clarify the prognostic implications of "silent myocardial ischemia" in different clinical contexts.
- To differentiate the prognosis of asymptomatic individuals with abnormal stress tests from symptomatic patients.
Summary:
- "Silent myocardial ischemia" is often applied to heterogeneous patient populations.
- Prognostic data from symptomatic patients are inappropriately extrapolated to asymptomatic individuals with abnormal ECG stress tests.
- These asymptomatic individuals generally exhibit a benign clinical course.
Impact:
- Accurate definition is crucial for appropriate patient management.
- Invasive investigations and treatments are typically not justified for properly defined "silent myocardial ischemia" in asymptomatic individuals.
- This distinction can prevent unnecessary medical interventions and associated risks.
Abstract:
During the last few years, the concept of "silent myocardial ischemia" has received special attention, particularly regarding its prognostic implications. Unfortunately a great variety of patients in different clinical settings have been included under the same definition. Thus, totally asymptomatic individuals are considered together with patients who have clinically evident stable or unstable angina pectoris, or patients in the post myocardial infarction phase. As a consequence, prognostic observations derived from clearly symptomatic cases are extrapolated to asymptomatic individuals in whom the only evidence of underlying coronary disease is an abnormal ECG stress test. The prognostic information available in this particular group shows that their clinical course is usually benign. Thus, invasive forms of investigation and management are not generally justified, in patients with properly define "silent myocardial ischemia".